glycoprotein
flow
cytometri
felin
infecti
periton
b
r
c
felin
glycoprotein
fagp
modifi
serum
concentr
glycan
moieti
diseas
fagp
hyposialyl
cat
felin
infecti
periton
fip
clinic
healthi
cat
cat
diseas
studi
aim
determin
whether
hyposialyl
fagp
influenc
phagocytosi
flow
cytometr
method
base
ingest
fluorescein
bacteria
adapt
felin
blood
use
assess
phagocytosi
leukocyt
incub
nonpatholog
fagp
purifi
sera
normal
concentr
agp
patholog
fagp
purifi
sera
mgml
hyposialyl
agp
flow
cytometr
method
provid
repeat
result
neutrophil
coeffici
variat
cv
monocyt
cv
also
high
individu
variabl
compar
salin
solut
nonpatholog
fagp
patholog
fagp
significantli
decreas
phagocytosi
neutrophil
monocyt
studi
demonstr
hyposialyl
fagp
downregul
phagocyt
activ
felin
neutrophil
felin
glycoprotein
fagp
work
acut
phase
protein
cat
paltrinieri
increas
serum
cat
sever
inflammatori
noninflammatori
condit
paltrinieri
et
al
paltrinieri
function
agp
includ
dampen
inflammatori
statu
minimis
tissu
damag
associ
releas
reactiv
oxygen
speci
character
last
phase
phagocyt
process
granulocyt
monocyt
recruit
tissu
inflamm
tilg
et
al
atemezem
et
al
hochepi
et
al
mirandaribera
et
al
addit
serum
concentr
posttransl
glycosyl
phosphoryl
agp
modifi
inflamm
diseas
glycan
moieti
influenc
sever
immunomodulatori
activ
agp
hochepi
et
al
carbohydr
moieti
modif
could
import
inflammatori
respons
may
also
respons
impair
innat
defenc
modifi
phagocyt
function
experi
focus
relationship
glycan
moieti
agp
involv
defens
respons
perform
experiment
desialyl
agp
due
difficulti
retriev
suffici
number
unhealthi
anim
mirandaribera
et
al
cat
hyposialyl
agp
link
link
sialic
acid
found
felin
infecti
periton
fip
ceciliani
et
al
fip
sustain
mutat
viral
variant
felin
coronaviru
fcov
abl
replic
macrophag
pedersen
develop
diseas
depend
immun
respons
host
pedersen
suggest
differ
number
lymphocyt
differ
concentr
molecul
involv
inflamm
immun
found
cat
fip
compar
fcovinfect
clinic
healthi
cat
kipar
et
al
berg
et
al
gelain
et
al
giordano
paltrinieri
hyposialyl
seem
uniqu
featur
fip
sinc
occur
diseas
fip
except
cat
infect
felin
leukemia
viru
felv
felin
immunodefici
viru
fiv
pocacqua
et
al
clinic
healthi
fcovinfect
cat
exhibit
transient
increas
hypersialyl
fagp
paltrinieri
et
al
relationship
degre
sialyl
agp
clinic
outcom
infect
hypothesis
due
involv
downregul
inflamm
possibl
hyposialyl
agp
may
increas
suscept
cat
alter
respons
phagocyt
aim
present
studi
determin
whether
hyposialyl
agp
purifi
unhealthi
cat
interfer
phagocyt
activ
felin
granulocyt
monocyt
fulfil
aim
use
flow
cytometr
method
previous
employ
cat
hoffmannjagielska
et
al
evalu
phagocytosi
fluorescein
bacteria
whole
blood
blood
sampl
taken
clinic
healthi
clientown
cat
inform
consent
routin
well
visit
therefor
accord
regul
institut
necessari
obtain
formal
authoris
anim
care
committe
blood
place
either
tube
lithium
heparin
uml
plain
tube
immedi
transport
laboratori
analys
within
h
specif
anticoagul
blood
use
perform
routin
hematolog
assess
phagocyt
activ
plain
tube
use
obtain
serum
centrifug
perform
biochem
analys
describ
inclus
criterion
absenc
clinic
sign
laboratori
abnorm
routin
laboratori
hematolog
biochem
screen
specif
biochem
analys
run
serum
use
autom
spectrophotomet
coba
mira
roch
basel
switzerland
use
reagent
provid
real
time
srl
viterbo
itali
measur
follow
analyt
total
protein
biuret
method
albumin
bromochresol
method
glucos
godpod
method
urea
ureas
method
creatinin
method
alanin
aminotransferas
alt
kinet
ifcc
method
aspart
aminotransferas
ast
kinet
ifcc
method
alkalin
phosphatas
alp
kinet
ifcc
method
cholesterol
codpodpap
method
triglycerid
gpopoppap
method
calcium
orthocresoftalein
method
phosphat
phosphomolibd
method
cglutamyl
transferas
ggt
kinet
ifcc
method
creatin
kinas
ck
cknac
method
serum
concentr
agp
also
measur
use
method
describ
cat
result
within
refer
interv
enrol
studi
routin
hematolog
perform
use
autom
laser
hematolog
analyz
sysmex
sysmex
co
chuoku
kobe
japan
alreadi
valid
felin
blood
tvedten
equip
multispeci
softwar
veterinari
use
follow
micrscop
analysi
may
grunwald
giemsa
stain
blood
smear
perform
differenti
leukocyt
count
heparin
blood
first
cat
enrol
studi
also
use
optim
flow
cytometr
method
describ
cat
evalu
precis
method
cat
regard
leukocyt
popul
interest
studi
differenti
cell
count
cat
normal
neutrophil
lymphocyt
monocyt
addit
six
heparin
sampl
cat
use
assess
phagocyt
respons
presenc
fagp
blood
place
tube
lithium
heparin
transport
laboratori
analys
within
h
differenti
cell
count
blood
cat
normal
neutrophil
lymphocyt
monocyt
phagocyt
activ
assay
heparinis
whole
blood
use
commerci
kit
phagotest
glycotop
biotechnolog
base
incub
blood
fluorescein
fluorescein
isothiocyan
fitclabel
escherichia
coli
follow
flow
cytometr
quantif
phagocytosi
aliquot
blood
prepar
assess
duplic
either
nonactiv
phagocytosi
basal
phagocyt
activ
rest
cell
incub
ice
activ
phagocytosi
phagocyt
activ
cell
incub
min
water
bath
follow
rapid
block
phagocytosi
immers
ice
incub
aliquot
mix
differ
amount
see
fitclabel
e
coli
incub
quench
solut
ad
inactiv
fluoresc
nonphagocytos
e
coli
cell
suspens
wash
twice
phosphat
buffer
salin
pb
centrifug
min
mix
lyse
solut
provid
kit
min
cell
wash
dna
stain
solut
ad
follow
incub
ice
min
phagocytosi
assess
nm
wavelength
use
flow
cytomet
facscalibur
becton
dickinson
equip
cellquest
softwar
becton
dickinson
analyz
volum
blood
contain
cell
gate
neutrophil
monocyt
gate
dot
plot
side
scatter
ssc
forward
scatter
fsc
analysi
supplementari
fig
gate
design
previou
studi
paltrinieri
et
al
base
cell
distribut
assess
use
monoclon
antibodi
leukocyt
popul
exclud
artifact
due
residu
fluoresc
aggreg
e
coli
intens
posit
dna
stain
assess
histogram
gate
popul
differenti
aploid
bacteria
diploid
nucleat
cell
diploid
cell
backgat
evalu
phagocytosi
two
histogram
neutrophil
monocyt
gener
data
express
percentag
phagocytos
cell
median
channel
fluoresc
mcf
emit
cell
mcf
proport
amount
ingest
bacteria
per
cell
data
record
logarithm
scale
valu
nonactiv
sampl
subtract
activ
sampl
determin
percentag
phagocyt
cell
mcf
sampl
differ
concentr
e
coli
test
preliminari
assay
first
test
e
coli
suspens
e
coliml
ad
aliquot
blood
test
perform
use
e
coli
suspens
intraassay
precis
assess
duplic
measur
five
sampl
analys
use
optimis
method
calcul
coeffici
variat
cv
meanstandard
deviat
felin
agp
purifi
two
pool
felin
sera
receiv
institut
routin
diagnost
investig
store
maximum
month
concentr
agp
assess
admiss
use
singl
radial
immunodiffus
srid
kit
felin
plate
tridelta
paltrinieri
et
al
sera
pool
base
agp
concentr
fortysix
sampl
cat
clinic
suspicion
fip
serum
agp
concentr
mgml
total
volum
ml
includ
patholog
pool
fiftynin
sera
total
volum
ml
clinic
healthi
cat
serum
agp
concentr
mgml
use
form
nonpatholog
pool
sinc
valu
within
refer
interv
laboratori
mgml
concentr
agp
assess
srid
mgml
nonpatholog
pool
mgml
patholog
pool
felin
agp
purifi
pool
describ
previous
ceciliani
et
al
addit
third
revers
phase
high
perform
liquid
chromatographi
rphplc
purif
step
remov
contamin
lipopolysaccharid
lp
might
interfer
vitro
experi
cell
addit
step
complet
remov
lp
purifi
protein
demonstr
use
lal
test
previou
studi
protein
peak
record
chromatograph
step
report
supplementari
fig
step
purif
protocol
protein
concentr
quantifi
spectrophotometr
measur
nm
fagp
concentr
determin
srid
presenc
fagp
purifi
protein
fraction
assess
western
blot
analysi
use
antifagp
polyclon
antibodi
rais
sheep
kindli
provid
professor
david
eckersal
univers
glasgow
uk
alkalin
phosphataseconjug
goat
antisheep
secondari
antibodi
western
blot
develop
use
amplifi
ap
immunblot
kit
biorad
agp
sialyl
characteris
western
blot
experi
use
biotinconjug
lectin
sambucu
nigra
agglutinin
snai
lgml
vector
laboratori
maackia
amurensi
agglutinin
maa
lgml
vector
laboratori
specif
sialic
acid
link
link
galactos
respect
glycan
analysi
fagplectin
bind
perform
follow
peroxidas
reaction
use
vectastain
abc
kit
vector
laboratori
describ
previous
ceciliani
et
al
develop
use
hrp
immunblot
assay
kit
biorad
laboratori
patholog
nonpatholog
agp
analys
blot
densitometr
analysi
perform
use
imagemast
softwar
amersham
bioscienc
analys
digit
imag
membran
acquir
scanner
order
display
profil
plot
fagp
peak
calcul
area
peak
effect
fagp
phagocytosi
assess
blood
six
clinic
healthi
cat
agp
concentr
rang
mgml
sampl
divid
six
aliquot
ad
follow
solut
salin
solut
place
ice
incub
nonactiv
neg
control
salin
solut
activ
phagocytosi
describ
activ
neg
control
baselin
phagocytosi
albumin
evalu
effect
phagocytosi
nonspecif
protein
ie
nonagp
nonpatholog
fagp
prepar
describ
agp
clinic
healthi
cattl
bovin
agp
bagp
serv
test
effect
phagocytosi
agp
speci
cat
patholog
fagp
prepar
describ
final
protein
concentr
well
mgml
aliquot
blood
ad
salin
solut
protein
list
use
assess
phagocyt
activ
duplic
aim
aliquot
use
fill
two
well
microtitr
plate
plate
incub
min
co
incub
blood
well
use
assess
phagocytosi
use
optimis
protocol
describ
statist
analys
perform
use
excel
spreadsheet
analyseit
set
macroinstruct
analyseit
softwar
version
non
parametr
analys
use
sinc
kolgomorov
smirnov
normal
test
demonstr
data
normal
distribut
result
record
incub
differ
experiment
condit
compar
friedmann
test
result
obtain
protein
compar
obtain
salin
solut
wilcoxon
sign
rank
pair
test
test
use
compar
result
obtain
non
patholog
felin
agp
obtain
patholog
felin
agp
bovin
agp
valu
consid
signific
p
applic
manufactur
protocol
demonstr
signal
exceed
maximum
visibl
fluoresc
supplementari
fig
convers
fluoresc
histogram
complet
visibl
use
e
coli
suspens
contain
respect
e
coliml
former
dilut
final
select
sinc
excess
bacteria
need
underestim
phagocyt
activ
dilut
fsc
vs
ssc
plot
show
phagocyt
cell
neutrophil
monocyt
although
residu
nonspecif
signal
found
lymphocyt
histogram
gate
neutrophil
monocyt
demonstr
moder
background
signal
nonactiv
cell
fig
c
tabl
strong
posit
signal
activ
neutrophil
posit
less
intens
activ
monocyt
also
show
high
individu
variabl
fig
tabl
intraassay
imprecis
modifi
method
high
nonactiv
sampl
supplementari
fig
exampl
histogram
obtain
nonactiv
neutrophil
activ
neutrophil
b
nonactiv
monocyt
c
activ
monocyt
gate
design
nonactiv
popul
identifi
percentag
nonspecif
phagocytosi
indic
comparison
histogram
c
b
respect
demonstr
increas
fluoresc
obtain
stimul
compar
nonactiv
cell
ie
cell
kept
ice
block
phagocytosi
detect
peak
area
present
non
activ
cell
tabl
low
cv
activ
sampl
although
individu
case
cv
especi
monocyt
purif
mg
nonpatholog
fagp
mg
patholog
fagp
recov
coomassi
blue
stain
confirm
agp
purifi
homogen
western
blot
analysi
confirm
purifi
protein
agp
sampl
supplementari
fig
densitometr
analysi
glycosyl
pattern
nonpatholog
patholog
fagp
fig
reveal
compar
nonpatholog
agp
sialic
acid
link
content
patholog
fagp
lectin
snai
decreas
sialic
acid
link
galactos
lectin
maa
decreas
result
confirm
patholog
fagp
hyposialyl
result
record
control
presenc
fagp
protein
summaris
fig
patholog
fagp
decreas
four
flow
cytometr
paramet
either
compar
salin
solut
compar
nonpatholog
fagp
signific
decreas
phagocytos
monocyt
compar
salin
solut
induc
bagp
signific
differ
found
nonpatholog
fagp
strong
individu
variabl
due
singl
cat
extrem
low
valu
monocyt
wide
individu
variabl
almost
paramet
inhibitori
activ
neutrophil
agpspecif
sinc
concentr
protein
ineffect
studi
demonstr
hyposialyl
fagp
purifi
unhealthi
cat
interfer
phagocytosi
phagocyt
activ
felin
neutrophil
monocyt
determin
flow
cytometr
protocol
cope
need
work
low
volum
blood
frequent
occur
cat
provid
opportun
work
whole
blood
paint
reliabl
pictur
cellcel
interact
occur
blood
main
limit
test
perform
whole
blood
substanc
plasma
cytokin
proinflammatori
molecul
even
endogen
agp
may
interfer
cell
respons
studi
design
adopt
studi
howev
minim
possibl
influenc
endogen
substanc
sinc
one
side
cat
clinic
healthi
normal
concentr
agp
side
aliquot
whole
blood
incub
salin
solut
therefor
differ
aliquot
activ
aliquot
amount
regard
fagp
type
sialyl
activ
therefor
like
differ
respons
record
incub
agp
albumin
actual
depend
presenc
activ
rather
endogen
molecul
similar
method
alreadi
employ
cat
hoffmannjagielska
et
al
hanel
et
al
chen
et
al
jasofriedmann
et
al
craig
et
al
webb
et
al
keegan
webb
howev
method
cite
specif
custom
felin
cell
preliminari
step
optimis
felin
blood
therefor
carri
follow
evalu
imprecis
approach
allow
us
tabl
result
obtain
five
clinic
healthi
cat
use
optimis
flow
cytometr
method
activ
differ
mean
sd
median
minmax
mean
sd
median
minmax
mean
sd
median
minmax
pmn
improv
qualiti
signal
decreas
number
e
coli
ad
cell
suspens
like
due
decreas
non
specif
bind
bacteria
cell
surfac
residu
posit
lymphocyt
possibl
due
nonspecif
adher
bacteria
low
phagocyt
activ
lymphocyt
tizard
parra
et
al
influenc
interpret
neutrophil
monocyt
sinc
phagocyt
activ
cell
evalu
gate
cell
popul
contain
lymphocyt
paltrinieri
et
al
use
optim
method
intraassay
imprecis
higher
nonactiv
cell
expect
dataset
low
mean
valu
westgard
accept
activ
cell
cv
compar
report
previous
hoffmannjagielska
et
al
neutrophil
higher
phagocyt
activ
monocyt
sinc
phagocytosi
monocyt
must
activ
cytokin
netea
et
al
tizard
result
monocyt
also
bias
high
imprecis
individu
variabl
second
part
experi
determin
phagocytosismodulatori
activ
fagp
incub
felin
blood
agp
purifi
healthi
unhealthi
anim
studi
focus
assess
phagocyt
respons
cat
fip
nevertheless
agp
purifi
sick
cat
strongli
hyposialyl
link
link
sialic
acid
magnitud
similar
found
cat
fip
ceciliani
et
al
find
coupl
high
agp
concentr
sera
sick
anim
also
consist
fip
duthi
et
al
suggest
although
clinic
diagnosi
fip
confirm
postmortem
like
patholog
sera
came
fip
affect
cat
last
step
purif
rphplc
remov
contamin
lp
reduc
purif
yield
alreadi
report
consequ
amount
purifi
agp
suffici
limit
number
replica
spite
limit
patholog
strongli
hyposialyl
fagp
downregul
phagocytosi
neutrophil
lesser
extent
monocyt
ad
concentr
similar
found
fip
high
variabl
monocyt
depend
intrins
variabl
respons
potenti
amplifi
low
number
cat
test
rather
true
effect
agp
possibl
influenc
subclin
condit
also
unlik
sinc
cat
clinic
clinicopatholog
healthi
fig
result
obtain
incub
whole
blood
salin
solut
neg
bovin
albumin
alb
nonpatholog
felin
agp
fagpnp
bovin
agp
bagp
patholog
felin
agp
fagpp
four
graph
display
percentag
phagocytos
neutrophil
median
channel
fluoresc
mcf
neutrophil
b
percentag
phagocytos
monocyt
c
mcf
monocyt
box
indic
iiii
interquartil
rang
iqr
horizont
line
indic
median
valu
whisker
extend
observ
within
quartil
minu
iqr
observ
within
iii
quartil
plu
iqr
asterisk
indic
valu
significantli
differ
neg
control
salin
solut
symbol
indic
valu
significantli
differ
non
patholog
fagp
regard
neutrophil
percentag
phagocyt
cell
mcf
significantli
lower
incub
patholog
fagp
compar
control
non
patholog
fagp
convers
regard
monocyt
percentag
phagocyt
cell
mcf
significantli
lower
incub
patholog
fagp
compar
control
nonpatholog
fagp
incub
bovin
agp
induc
signific
decreas
percentag
phagocyt
cell
compar
control
nonpatholog
fagp
human
cattl
agp
modul
monocyt
neutrophil
function
vasson
et
al
lecchi
et
al
rinaldi
et
al
mirandaribera
et
al
agp
interact
target
cell
glycan
moieti
experiment
desialyl
inhibit
immunomodulatori
activ
apoptosi
protect
function
degranulatori
inhibitori
activ
mirandaribera
et
al
find
hyposialyl
fagp
purifi
unhealthi
cat
downregul
phagocytosi
remark
give
insight
relationship
sialyl
degre
agp
modul
function
diseas
posttransl
modif
protein
occur
result
studi
allow
us
formul
hypothesi
mechan
respons
find
hyposialyl
found
specif
fip
clinic
healthi
fcov
infect
cat
ceciliani
et
al
paltrinieri
et
al
although
previou
report
perform
method
differ
report
studi
suggest
phagocytosi
suppress
cat
wit
fip
knotek
et
al
hyposialyl
fagp
found
downregul
phagocytosi
may
influenc
clinic
outcom
fcov
infect
induc
failur
cellular
respons
viru
macrophag
neutrophil
involv
fip
immunopatholog
abund
hardli
effect
popul
pyogranulomat
lesion
kipar
et
al
paltrinieri
et
al
would
interest
investig
whether
cellmedi
function
hamper
desialyl
fagp
among
potenti
agp
modul
apoptosi
variat
glycan
moieti
william
et
al
de
vri
et
al
kagaya
et
al
could
interest
sinc
lymphocyt
apoptosi
occur
cat
fip
takano
et
al
fcovinfect
clinic
healthi
cat
paltrinieri
et
al
conclus
use
modifi
flow
cytometr
method
evalu
phagocytosi
felin
whole
blood
hyposialyl
fagp
downregul
neutrophil
phagocytosi
thu
support
hypothesi
posttransl
modif
agp
contribut
pathogenesi
diseas
involv
cellmedi
respons
fip
ceciliani
et
al
experi
phagocyt
activ
fip
affect
cat
envisag
confirm
hypothesi
